Kara S Cox (Kara Cox)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Respiratory Tract

Top Venues

Human vaccines & immunotherapeutics

Science translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin L Russell, Richard E Rupp, Javier O Morales-Ramirez, Clemente Diaz-Perez, Charles P Andrews, Andrew W Lee, Tyler S Finn, Kara S Cox, Amy Falk Russell, Margaret M Schaller, Jason C Martin, Donna M Hyatt, Sabrina Gozlan-Kelner, Androniki Bili, Beth-Ann G Coller
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults. Human vaccines & immunotherapeutics 18 (5) (2022)
Antonios O Aliprantis, Christine A Shaw, Paul Griffin, Nicholas Farinola, Radha A Railkar, Xin Cao, Wen Liu, Jeffrey R Sachs, Christine J Swenson, Heather Lee, Kara S Cox, Daniel S Spellman, Colleen J Winstead, Igor Smolenov, Eseng Lai, Tal Zaks, Amy S Espeseth, Lori Panther
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Human vaccines & immunotherapeutics 17 (5) (2020)
Aimin Tang, Zhifeng Chen, Kara S Cox, Hua-Poo Su, Cheryl Callahan, Arthur Fridman, Lan Zhang, Sangita B Patel, Pedro J Cejas, Ryan Swoyer, Sinoeun Touch, Michael P Citron, Dhanasekaran Govindarajan, Bin Luo, Michael Eddins, John C Reid, Stephen M Soisson, Jennifer Galli, Dai Wang, Zhiyun Wen, Gwendolyn J Heidecker, Danilo R Casimiro, Daniel J DiStefano, Kalpit A Vora
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein. Nature communications 10 (1) (2019)
Mohamed Abdel-Mohsen, Leticia Kuri-Cervantes, Judith Grau-Expósito, Adam M Spivak, Racheal A Nell, Costin Tomescu, Surya Kumari Vadrevu, Leila B Giron, Carla Serra-Peinado, Meritxell Genescà, Josep Castellví, Guoxin Wu, Perla Mariana Del Río-Estrada, Mauricio Gonzalez Navarro, Kenneth Lynn, Colin T King, Sai Vemula, Kara S Cox, Yanmin Wan, Qingsheng Li, Karam Mounzer, Jay Kostman, Ian Frank, Mirko Paiardini, Daria J Hazuda, Gustavo Reyes-Terán, Douglas Richman, Bonnie J Howell, Pablo Tebas, Javier Martinez-Picado, Vicente Planelles, Maria José Buzón, Michael R Betts, Luis J Montaner
CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Science translational medicine 10 (437) (2019)